Painful Diabetic Neuropathy

Aetiology and Nonpharmacological Treatment
  • Solomon Tesfaye
Part of the Contemporary Endocrinology book series (COE, volume 7)

Abstract

Pain is probably the most distressing symptom of diabetic neuropathy (1). The features of pain in diabetic neuropathy were clearly documented by Pavy (2), who observed, that it was of burning and unremitting quality often with a nocturnal exacerbation. Indeed the quality of neuropathic pain has been described as burning, shooting, lancinating, prickling, and aching in character, often with many of these symptoms manifesting in the same patient (3). Some patients describe these symptoms as the feeling of walking barefoot on hot sand or pebbles. Others describe an odd sensation of their legs feeling swollen. The intensity of neuropathic pain is also variable among different individuals and often varies with time in the same individual. Some patients may have mild paresthesia in one or two toes; others may have intolerable unremitting pain involving both legs (4). Most patients with chronic, painful neuropathy have a moderate background pain with relatively short intervals of peak neuropathic pain. Sleep is often disturbed because of the nocturnal exacerbation of these symptoms, in addition to allodynia (contact hypersensitivity to bed clothes) (4). In some patients, neuropathic pain can be so disabling as to lead to loss of employment, reduction in exercise tolerance, and hence interference with daily activities, a reduction in recreational activities, and depression (4,5).

Keywords

Burning Retina Neuropathy Neurol Lidocaine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tesfaye S, Price DE. Therapeutic approaches in diabetic neuropathy and neuropathic pain. In: Boulton AJM, ed. Diabetic Neuropathy. Marius Press, Carnforth, Lanceshire, UK, 1997, pp. 159–181.Google Scholar
  2. 2.
    Pavy FW. Introductory address to the discussion on the clinical aspect of glycosuria. Lancet 1885;ii:1085–1087.CrossRefGoogle Scholar
  3. 3.
    Young RJ. The management of diabetic neuropathy. In: Pickup J, Williams G, eds. Textbook of Diabetes, vol 2. Blackwell Science, Oxford, UK, 1997, pp. 51.1-51.13.Google Scholar
  4. 4.
    Watkins PJ. Pain and diabetic neuropathy. Br Med J 1984;288:168–169.CrossRefGoogle Scholar
  5. 5.
    Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696–1701.CrossRefGoogle Scholar
  6. 6.
    Watkins PJ, Edmunds ME. Clinical features of diabetic neuropathy. In: Pickup J, Williams G, eds. Textbook of Diabetes, Vol 2. Blackwell Sciences, Oxford, UK, 1997, pp. 50.1-50.19.Google Scholar
  7. 7.
    Tesfaye S. Diabetic neuropathy: current treatment and potential therapeutic approaches. Diab Nutr Metab 1994;7:375–379.Google Scholar
  8. 8.
    Ward JD, Tesfaye S. Pathogenesis of human diabetic neuropathy. In: Pickup J, Williams G, eds. Textbook of Diabetes, Vol 2. Blackwell Sciences, Oxford, UK, 1997, pp. 49.1-9.19.Google Scholar
  9. 9.
    Editorial. Pain perception in diabetic neuropathy. Lancet1985;i:83, 84.Google Scholar
  10. 10.
    Boulton AJM. Causes of neuropathic pain. Diabetic Med 1993;10(Suppl 2):87S–88S.PubMedCrossRefGoogle Scholar
  11. 11.
    Young RJ. Structural functional interactions in the natural history of diabetic polyneuropathy: a key to the understanding of neuropathic pain? Diabetic Med 1993;10(Suppl 2):89S–90S.PubMedCrossRefGoogle Scholar
  12. 12.
    Brown MJ, Martin JR, Asbury AK. Painful diabetic neuropathy: a morphometric study. Arch Neurol 1976;33:164–171.PubMedCrossRefGoogle Scholar
  13. 13.
    Said G. Progressive centipetal degeneration of axons in small fibre diabetic neuropathy. Brain 1983;106:791–807.PubMedCrossRefGoogle Scholar
  14. 14.
    Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072–1082.PubMedCrossRefGoogle Scholar
  15. 15.
    Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatr 1983;26:491–499.CrossRefGoogle Scholar
  16. 16.
    Britland ST, Young RJ, Sharma AK, Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fibre degeneration and regeneration. Diabetes 1990;39:898–907.PubMedCrossRefGoogle Scholar
  17. 17.
    Townsend CA, Malik RA, Thompson SD, Tesfaye S, Veves A, Sharma AK, Boulton AJM, Ward JD. Do neurophysiological and pathological abnormalities discriminate painful from painless human diabetic neuropathy? Diabetologia 1992; 35:A157.Google Scholar
  18. 18.
    Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329–335.PubMedCrossRefGoogle Scholar
  19. 19.
    Asbury AK, Fields HL. Pain due to peripheral nerve damage: an hypothesis. Neurology 1984;34:1587–1590.PubMedCrossRefGoogle Scholar
  20. 20.
    Dandona P, Fonseca V, Thomas PK, Llewelyn G, Bolger JP. Painful diabetic neuropathy. Lancet 1985;1:697.PubMedCrossRefGoogle Scholar
  21. 21.
    Fowler TJ, Ochoa J. Unmyelinated fibres in normal and compressed peripheral nerves of the baboon: a quantitative electronmicroscopic study. Neuropathol Appl Neurobiol. 1975;1:247–265.CrossRefGoogle Scholar
  22. 22.
    Scadding JW. Development of on going activity, mechanosensitivity and adrenaline sensitivity in severed peripheral nerve axons. Exp Neurol 1981;73:345–364.PubMedCrossRefGoogle Scholar
  23. 23.
    Wall PD, Gutnick M. Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating from a neuroma. Exp Neurol 1974;43:580–593.PubMedCrossRefGoogle Scholar
  24. 24.
    Govrin-Lippman R, Devor M. Ongoing activity in severed nerves. Sources and variation with time. Brain Res 1978;159:406–410.CrossRefGoogle Scholar
  25. 25.
    Korenman EMD, Devor M. Ectopic adrenergic sensitivity in damaged peripheral nerve axons in the rat. Exp Neurol 1981;72:63.PubMedCrossRefGoogle Scholar
  26. 26.
    Thomas PK, Scadding JW. Treatment of pain in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 216–222.Google Scholar
  27. 27.
    Asbury AK. Focal and multifocal neuropathies of diabetes. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia 1987, pp. 45–55.Google Scholar
  28. 28.
    Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266–1274.PubMedCrossRefGoogle Scholar
  29. 29.
    Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971–979.PubMedCrossRefGoogle Scholar
  30. 30.
    Loeser JD, Ward AA. Some effects of deafferentiation on neurons of the cat spinal cord. Arch Neurol 1967;17:629–636.PubMedCrossRefGoogle Scholar
  31. 31.
    Howe JF, Loeser JD, Calvin WH. Mechanosensitivity of dorsal root ganglia and chronically injured axons: a physiological basis for the radicular pain of nerve root compression. Pain 1977;3:25–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Wall PD, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983;17:321–339.PubMedCrossRefGoogle Scholar
  33. 33.
    Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterio-venous shunting? Diabetologia 1982;22:6–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Edmunds ME, Roberts VC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia 1982;22:9–15.CrossRefGoogle Scholar
  35. 35.
    Ward JD, Simms JM, Knight G, Boulton AJM, Sandier DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 1983;76:1011–1014.PubMedGoogle Scholar
  36. 36.
    Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia 1984;27:563–567.PubMedCrossRefGoogle Scholar
  37. 37.
    Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving H-H. The effect of metabolic control on haemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985;34:1301–1305.PubMedCrossRefGoogle Scholar
  38. 38.
    Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction velocity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 1992;35:155–159.PubMedCrossRefGoogle Scholar
  39. 39.
    Boulton AJM, Hardisty CA, Worth RC, Drury J, Ward JD. Elevated glycosylated haemoglobin in diabetic neuropathy. Acta Diabet Lat 1982;19:345–349.CrossRefGoogle Scholar
  40. 40.
    Tesfaye S, Stevens L, Stephenson J, Fuller JH, Plater M, Ionescu-Tirgovigtec, Nuber A, Pozza G, Ward JD. The prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377–1384.PubMedCrossRefGoogle Scholar
  41. 41.
    Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418–423.PubMedGoogle Scholar
  42. 42.
    Steel JM, Young RJ, Lloyd CG, Clark BF. Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications. BMJ 1987;294:859–862.PubMedCrossRefGoogle Scholar
  43. 43.
    Boulton AJM, Drury, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982;5:386–390.PubMedCrossRefGoogle Scholar
  44. 44.
    Morley GK, Mooradian AD, Levine AL, Morley JE. Mechanisms of pain in diabetic peripheral neuropathy: effect of glucose on pain perception in humans. Am J Med 1984;77:79–82.PubMedCrossRefGoogle Scholar
  45. 45.
    Chan AW, MacFarlane IA, Bowsher DR, Wells JCD. Does acute hyperglycaemia influence heat pain thresholds? J Neurol Neurosurg Psychiatr 1988;51:688–690.PubMedCrossRefGoogle Scholar
  46. 46.
    Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med 1936;57:308–366.Google Scholar
  47. 47.
    Martin MM. Diabetic neuropathy. Brain 1953;76:594–624.PubMedCrossRefGoogle Scholar
  48. 48.
    Ellenberg M. Diabetic neuropathy precipitating after institution of diabetic control. Am J Med Sci 1958;236:466–471.PubMedGoogle Scholar
  49. 49.
    Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl) 1986;72:157–163.CrossRefGoogle Scholar
  50. 50.
    Caravati CM. Insulin neuritis: a case report. Va Med Mon 1933;59:745–746.Google Scholar
  51. 51.
    Dandona P, Boiger J, Boag F, Abrams JD. Rapidly progressive retinopathy following strict diabetic control. B Med J 1985;290:845–896.CrossRefGoogle Scholar
  52. 52.
    Chan AW, MacFarlane IA, Bowsher DR, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus; comparison with non-diabetic population. Pain Clinic 1990;3:147–159.Google Scholar
  53. 53.
    Ward JD. The diabetic leg. Diabetologia 1982;22:141–147.PubMedCrossRefGoogle Scholar
  54. 54.
    Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175–184.PubMedCrossRefGoogle Scholar
  55. 55.
    The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277–299.Google Scholar
  56. 56.
    Dyck PJ. Detection, characterisation, and staging of polyneuropathy. Muscle Nerve 1988;11:21–32.PubMedCrossRefGoogle Scholar
  57. 57.
    Tomlinson DR. The pharmacology of diabetic neuropathy. Diab Metab Rev. 1992;8:67–84.CrossRefGoogle Scholar
  58. 58.
    Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia 1994;37:847–854.PubMedCrossRefGoogle Scholar
  59. 59.
    Cameron NE, Cotter MA. The relationship of vascular changes and metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diab Metab Rev 1994;10:189–224.CrossRefGoogle Scholar
  60. 60.
    Malik RA, Tesfaye S, Thompson SD, Veves A, Hunter A, Sharma A, Ward JD, Boulton A. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvascular Res 1994;48:236–245.CrossRefGoogle Scholar
  61. 61.
    Cameron NE, Cotter MA. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy. Diabetic Med 1993;10:593–605.PubMedCrossRefGoogle Scholar
  62. 62.
    Reja A, Tesfaye S, Harris N, Ward JD. Improvement in nerve conduction and quantitative sensory tests after treatment with lisinopril. Diabetic Med 1995;12:307–309.PubMedCrossRefGoogle Scholar
  63. 63.
    Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;48:869–872.PubMedGoogle Scholar
  64. 64.
    Dejgard A, Petersen P, Kastrup J. Mexiletine for the treatment of chronic painful diabetic neuropathy. Lancet 1988;ii:9–11.CrossRefGoogle Scholar
  65. 65.
    Kastrup J, Angelo H, Petersen P, Dejgard A, Hilsted J. Treatment of chronic painful neuropathy with intravenous lidocaine infusion. B Med J 1986;292:173.CrossRefGoogle Scholar
  66. 66.
    Capsaicin Study Group. The effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992;15:159–165.CrossRefGoogle Scholar
  67. 67.
    Foster AV, Eaton C, McConville DO, Edmonds ME. Application of opsite film: a new and effective treatment for painful diabetic neuropathy. Diabetic Med 1994;11:768–772.PubMedCrossRefGoogle Scholar
  68. 68.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977–986.CrossRefGoogle Scholar
  69. 69.
    Long DM, Erickson D, Campbell J, North R. Electrical stimulation of the spinal cord and peripheral nerves for pain control—10 years’ experience. Applied Neurophysiology 1981;44:207–217.PubMedGoogle Scholar
  70. 70.
    Ray CHD. Implantation of spinal cord stimulators for relief of chronic and severe pain. In: Cauthen JC, ed. Lumbar Spine Surgery. Indications, Techniques, Failures and Alternatives, 2nd ed. William and Wilkins, Baltimore, 1988, pp. x–x.Google Scholar
  71. 71.
    Long DM, Erickson DE. Stimulation of the posterior columns of the spinal cord for the relief of intractable pain. Surgical Neurology 1975;4:134–141.PubMedGoogle Scholar
  72. 72.
    Simpson BA. Spinal cord stimulation in 60 cases of intractable pain. J Neurol Neurosurg Psychiatr 1991;54:196–199.PubMedCrossRefGoogle Scholar
  73. 73.
    Watkins ES, Koeze TH. Spinal cord stimulation and pain relief. Br Med J 1993;307:462.CrossRefGoogle Scholar
  74. 74.
    Thorsteinsson G. Management of painful diabetic neuropathy. JAMA 1977;238:2697.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Solomon Tesfaye

There are no affiliations available

Personalised recommendations